NEUWAY Pharma GmbH

NEUWAY Pharma GmbH, Bonn, Germany is focusing on the preclinical and clinical development of innovative therapeutics for the treatment of brain diseases using its proprietary CNS Drug Delivery Technology. This technology is based on a protein that naturally forms capsules, named Engineered Protein Capsules (EnPC®). EnPCs may be used as a carrier to transport highly active drug substances – ranging from small molecules to large nucleic acid strands – across the blood-brain barrier (BBB) after intravenous (i.v.) injection.

NEUWAY uses this technology to encapsulate active drug substances that do not cross the BBB to successfully treat severe orphan brain diseases with a very high medical need. Besides these in-house projects, NEUWAY plans to partner its CNS Drug Delivery Technology with pharmaceutical or biotech companies, preferably if large indications, like Alzheimer’s disease, are addressed.

  • Ausrichtungen
    • Therapie-Entwickler
  • Gegründet

    2019
  • Aktualisiert am

    25.07.2019